Elite Pharmaceuticals (ELTP) EBT Margin (2009 - 2026)
Elite Pharmaceuticals (ELTP) posted EBT Margin of 49.26% for fiscal Q2 2027 (quarter ended Sep 30, 2026), up 6.06 percentage points from 43.20% a year earlier and up 25.41 percentage points from the prior quarter.
Elite Pharmaceuticals (ELTP) EBT Margin (2009 - 2026) Analysis & Trends
For the trailing twelve months through Sep 30, 2026, EBT Margin at Elite Pharmaceuticals was 47.76%, up 28.48 percentage points year-over-year; for FY2026 (ended Mar 31, 2026), it came in at 38.16%, up 38.28 percentage points from FY2025.
- Annual EBT Margin shows a five-year change of +21.83 percentage points (FY2021 to FY2026).
- In prior fiscal years, Elite Pharmaceuticals' EBT Margin was -0.12% in FY2025 (-1.00 pp), 0.88% in FY2024 (-10.79 pp), 11.67% in FY2023 (-7.87 pp) and 19.54% in FY2022 (+3.21 pp).
- Quarterly EBT Margin has run from a low of -74.16% in fiscal Q3 2025 to a high of 65.95% in fiscal Q3 2026 over five years.
- On a year-over-year basis, EBT Margin increased in five of the last eight quarters, with an average year-over-year change of +28.18 percentage points.
- The strongest year-over-year quarter for EBT Margin in the past five years was fiscal Q3 2026, with a gain of 140.11 percentage points; the weakest was fiscal Q3 2025, with a drop of 73.56 percentage points.
- According to Business Quant data, EBT Margin for the three prior fiscal quarters was 23.85% (Q1 2027), 51.18% (Q4 2026) and 65.95% (Q3 2026).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBT Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,284.09 Bn | 1,257.70 Bn | 20.46 Bn | 34.46% |
| 2 | Johnson & Johnson | 682.16 Bn | 602.02 Bn | 17.30 Bn | 0.13% |
| 3 | AbbVie | 521.78 Bn | 489.79 Bn | 13.12 Bn | 27.75% |
| 4 | Merck | 360.40 Bn | 323.34 Bn | 13.19 Bn | 30.74% |
| 5 | Novartis Ag | 311.92 Bn | 285.16 Bn | - | - |
| 6 | Astrazeneca | 285.57 Bn | 259.09 Bn | 13.26 Bn | 26.27% |
| 7 | Amgen | 251.35 Bn | 203.01 Bn | 7.58 Bn | 45.21% |
| 8 | Gilead Sciences | 208.52 Bn | 183.63 Bn | 6.73 Bn | 36.90% |
| 9 | Pfizer | 164.76 Bn | 112.12 Bn | 12.56 Bn | 20.41% |
| 10 | Elite Pharmaceuticals | 401.23 Mn | 274.64 Mn | 15.99 Mn | 49.26% |
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2026 | 49.26% |
| Jun 30, 2026 | 23.85% |
| Mar 31, 2026 | 51.18% |
| Dec 31, 2025 | 65.95% |
| Sep 30, 2025 | 43.20% |
| Jun 30, 2025 | -1.40% |
| Mar 31, 2025 | 60.08% |
| Dec 31, 2024 | -74.16% |
| Sep 30, 2024 | -50.42% |
| Jun 30, 2024 | 4.51% |
| Mar 31, 2024 | 11.31% |
| Dec 31, 2023 | -0.61% |
| Sep 30, 2023 | -19.30% |
| Jun 30, 2023 | 14.44% |
| Mar 31, 2023 | -9.91% |
| Dec 31, 2022 | 32.53% |
| Sep 30, 2022 | 17.78% |
| Jun 30, 2022 | 3.99% |
| Mar 31, 2022 | 8.97% |
| Dec 31, 2021 | 25.44% |
Elite Pharmaceuticals EBT Margin API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=ebt-margin&ticker=ELTP&period=max&api_key=YOUR_API_KEY
import requests
url = "https://data.businessquant.com/historic"
params = {"slug": "ebt-margin", "ticker": "ELTP", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()
const res = await fetch("https://data.businessquant.com/historic?slug=ebt-margin&ticker=ELTP&period=max&api_key=YOUR_API_KEY");
const data = await res.json();